Cooperative Studies Scientific Evaluation Committee, Notice of Meeting, 22515 [2020-08452]

Download as PDF Federal Register / Vol. 85, No. 78 / Wednesday, April 22, 2020 / Notices By direction of the Secretary: Danny S. Green, VA PRA Clearance Officer, Office of Quality, Performance and Risk, Department of Veterans Affairs. Dated: April 16, 2020. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2020–08453 Filed 4–21–20; 8:45 am] BILLING CODE 8320–01–P [FR Doc. 2020–08452 Filed 4–21–20; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERAN AFFAIRS DEPARTMENT OF VETERANS AFFAIRS Delegation of Authority khammond on DSKJM1Z7X2PROD with NOTICES ACTION: 17:59 Apr 21, 2020 Jkt 250001 On March 13, 2020, the President declared a national emergency recognizing the threat that the ongoing outbreak of COVID–19, the disease caused by the novel (new) coronavirus known as SARS-CoV–2 (‘‘the virus’’), poses to the Nation’s healthcare systems. On April 10, 2020, the President of the United States issued a Memorandum for the Secretary of Veterans Affairs, ‘‘Authorizing the Exercise of Authority under Public Law 85–804.’’ The Memorandum authorizes the Secretary to exercise authority with respect to contracts performed in support of efforts by the Department of Veterans Affairs to combat COVID–19. The President authorized and directed the Secretary of Veterans Affairs to publish this memorandum in the Federal Register. The text of the memorandum is set out below. SUPPLEMENTARY INFORMATION: SUMMARY: The Department of Veterans Affairs gives notice under the Federal Advisory Committee Act that the Cooperative Studies Scientific Evaluation Committee will hold a meeting on July 15, 2020 at 20F Conference Center, 20 F Street NW, Washington, DC 20001. The meeting will begin at 8:30 a.m. and end at 3:30 p.m. The Committee advises the Chief Research and Development Officer on the relevance and feasibility of proposed projects and the scientific validity and propriety of technical details, including protection of human subjects. The session will be open to the public for approximately 30 minutes at the start of the meeting for the discussion of administrative matters and the general status of the program. The remaining portion of the meeting will be closed to the public for the Committee’s review, discussion, and evaluation of research and development applications. During the closed portion of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research proposals and similar documents, and the medical records of patients who are study subjects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. As provided by section 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B). The Committee will not accept oral comments from the public for the open portion of the meeting. Those who plan to attend or wish additional information should contact Grant Huang, MPH, Ph.D., Director, Cooperative Studies Program (10X2), Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC 20420, at (202) 443– 5700 or by email at grant.huang@va.gov. Those wishing to submit written comments may send them to Dr. Huang at the same address and email. VerDate Sep<11>2014 Department of Veterans Affairs. Notice. AGENCY: Cooperative Studies Scientific Evaluation Committee, Notice of Meeting Signing Authority The Secretary of Veterans Affairs approved this document and authorized the undersigned to sign and submit the document to the Office of the Federal Register for publication electronically as an official document of the Department of Veterans Affairs. Pamela Powers, Chief of Staff, Performing the Delegable Duties of the Deputy Secretary, Department of Veterans Affairs, approved this document on April 16, 2020, for publication. Jeffrey M. Martin, Assistant Director, Office of Regulation Policy & Management, Office of the Secretary, Department of Veterans Affairs. MEMORANDUM FOR THE SECRETARY OF VETERANS AFFAIRS SUBJECT: Authorizing the Exercise of Authority Under Public Law 85–804 By the authority vested in me as President by the Constitution and the laws of the United States of America, I hereby direct the following: Section 1. On March 13, 2020, I declared a national emergency recognizing the threat that the ongoing PO 00000 Frm 00123 Fmt 4703 Sfmt 4703 22515 outbreak of COVID–19, the disease caused by the novel (new) coronavirus known as SARS-CoV–2 (‘‘the virus’’), poses to the Nation’s healthcare systems. I also determined on the same day that the COVID–19 outbreak constitutes an emergency, of nationwide scope, pursuant to section 501(b) of the Robert T. Stafford Disaster Relief and Emergency Assistance Act (42 U.S.C. 5191(b)). On March 18, 2020, I declared that health and medical resources needed to respond to the spread of COVID–19 meet the criteria specified in section 101(b) of the Defense Production Act of 1950 (50 U.S.C. 4511(b)), including that they are essential to the national defense. Sec. 2. The Secretary of Veterans Affairs is authorized to exercise authority under Public Law 85–804, as amended (50 U.S.C. 1431 et seq.), to the same extent and subject to the same conditions and limitations as the head of an executive department or agency listed in section 21 of Executive Order 10789 of November 14, 1958 (Authorizing Agencies of the Government to Exercise Certain Contracting Authority in Connection with National-Defense Functions and Prescribing Regulations Governing the Exercise of Such Authority), as amended, with respect to contracts performed in support of efforts by the Department of Veterans Affairs to combat the virus. This authority may only be exercised with regard to transactions directly responsive to the COVID–19 national emergency. Sec. 3. The Department of Veterans Affairs is exercising functions in connection with the national defense in the course of contributing to the Nation’s response to the ongoing outbreak of COVID–19. I deem that the authorization provided in this memorandum and actions taken pursuant to that authorization would facilitate the national defense. Sec. 4. This memorandum shall terminate on September 30, 2020. Sec. 5. (a) Nothing in this memorandum shall be construed to impair or otherwise affect: (i) The authority granted by law to an executive department or agency, or the head thereof; or (ii) the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals. (b) This memorandum shall be implemented consistent with applicable law and subject to the availability of appropriations. (c) This memorandum is not intended to, and does not, create any right or benefit, substantive or procedural, E:\FR\FM\22APN1.SGM 22APN1

Agencies

DEPARTMENT OF VETERANS AFFAIRS

[Federal Register Volume 85, Number 78 (Wednesday, April 22, 2020)]
[Notices]
[Page 22515]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08452]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Cooperative Studies Scientific Evaluation Committee, Notice of 
Meeting

    The Department of Veterans Affairs gives notice under the Federal 
Advisory Committee Act that the Cooperative Studies Scientific 
Evaluation Committee will hold a meeting on July 15, 2020 at 20F 
Conference Center, 20 F Street NW, Washington, DC 20001. The meeting 
will begin at 8:30 a.m. and end at 3:30 p.m.
    The Committee advises the Chief Research and Development Officer on 
the relevance and feasibility of proposed projects and the scientific 
validity and propriety of technical details, including protection of 
human subjects.
    The session will be open to the public for approximately 30 minutes 
at the start of the meeting for the discussion of administrative 
matters and the general status of the program. The remaining portion of 
the meeting will be closed to the public for the Committee's review, 
discussion, and evaluation of research and development applications.
    During the closed portion of the meeting, discussions and 
recommendations will deal with qualifications of personnel conducting 
the studies, staff and consultant critiques of research proposals and 
similar documents, and the medical records of patients who are study 
subjects, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy. As provided by section 10(d) 
of Public Law 92-463, as amended, closing portions of this meeting is 
in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B).
    The Committee will not accept oral comments from the public for the 
open portion of the meeting. Those who plan to attend or wish 
additional information should contact Grant Huang, MPH, Ph.D., 
Director, Cooperative Studies Program (10X2), Department of Veterans 
Affairs, 810 Vermont Avenue NW, Washington, DC 20420, at (202) 443-5700 
or by email at [email protected]. Those wishing to submit written 
comments may send them to Dr. Huang at the same address and email.

    Dated: April 16, 2020.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-08452 Filed 4-21-20; 8:45 am]
 BILLING CODE 8320-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.